ASAM Levels of Care in Addiction Treatment: A Complete Guide to Residential Levels 3.1–3.7

Introduction: Why the Right Level of Care Changes Everything

The scale of America’s addiction crisis is difficult to overstate. According to SAMHSA’s 2024 National Survey on Drug Use and Health, 16.8% of people aged 12 or older (roughly 48.4 million Americans) had a past-year substance use disorder. Yet fewer than 10% of those who need treatment receive it at a specialized facility. The gap is staggering, and it is more than a matter of access.

Even among those who do reach treatment, a quieter problem persists: getting the right level of care. A patient placed in a program that is too intensive may disengage. A patient placed in one that is not intensive enough may relapse or face a medical emergency. When patients are forced to switch providers midway through recovery to access a different intensity of care, the disruption itself can derail progress.

This is where the ASAM Criteria comes in. Developed by the American Society of Addiction Medicine, it is the gold-standard framework for matching patients to the appropriate level of treatment. This guide is anchored in the ASAM Criteria 4th Edition, published in 2023, the first major structural update in more than a decade.

This article serves two audiences. Clinicians will find guidance on placement logic and transition criteria. Patients and families will find plain-language explanations of what each residential level means in practice, and why a unified, multi-level network can eliminate the dangerous gaps that occur when providers change mid-treatment.

What Is the ASAM Criteria? The Framework Behind Every Placement Decision

The ASAM Criteria is the most widely used and comprehensive set of standards for the placement, continued service, and transfer of patients with addiction and co-occurring conditions. It was first developed in the 1980s to establish one national set of criteria for outcome-oriented care.

The 4th Edition, published in late 2023 in partnership with the Hazelden Betty Ford Foundation, represents the most significant overhaul in over ten years. The framework organizes treatment into four broad levels (1 through 4), with decimal numbers expressing further gradations of intensity. Level 3 encompasses all residential care.

Every placement decision is driven by a multidimensional assessment. Historically, this involved six dimensions: acute intoxication and withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and recovery environment.

A pivotal 4th Edition change replaced the old Dimension 4 (Readiness to Change) with a new Dimension 6: Person-Centered Considerations, which now explicitly incorporates social determinants of health, patient preferences, and the need for motivational enhancement.

A core ASAM principle is essential to understand: clinicians use these criteria to determine the least intensive yet safe and effective option. Patients do not need to “fail” at a lower level before accessing more intensive care. Three decades of peer-reviewed research show that patients optimally matched to the right level of care have better outcomes, including lower hospital utilization, lower attrition, and reduced substance use at follow-up.

Key 4th Edition Changes Every Patient, Family Member, and Clinician Should Know

Most online resources still use outdated 3rd Edition language, making this context critical.

• Elimination of Level 3.3 as a standalone level. The former Clinically Managed Population-Specific High-Intensity Residential level no longer exists as a discrete tier. A slower pace of treatment is now a patient-centered consideration applicable at any level.
• Integration of withdrawal management into Level 3.5. The former Level 3.2-WM has been folded into Level 3.5, reflecting that withdrawal management and residential treatment should be seamlessly integrated, not siloed.
• Co-occurring enhanced (COE) designations. New sub-levels, including 3.5 COE and 3.7 COE, serve patients with more severe mental health needs. Approximately 21.2 million adults have co-occurring SUD and mental illness.
• New Level 1.0 Long-Term Remission Monitoring. This provides ongoing recovery checkups and rapid reengagement, reflecting the chronic care model of addiction.
• New Level 3.7 BIO designation. For patients with significant medical comorbidities requiring elevated biomedical monitoring within the residential setting.
• Telehealth integration. An entire chapter is now dedicated to telehealth and health technologies, emphasizing improved access and smoother step-down transitions.

The regulatory stakes are real. Illinois adopted the 4th Edition as its standard on July 1, 2025, and California is in active transition. Providers not aligned with the 4th Edition risk reimbursement and licensing complications.

Understanding the Residential Spectrum: “Clinically Managed” vs. “Medically Monitored” Care

This foundational distinction is the single most important structural divide in the residential continuum, yet most competitor content ignores it entirely.

Clinically managed care (Levels 3.1 and 3.5) is directed by nonphysician addiction specialists. It is appropriate for patients whose primary needs are behavioral, psychological, and social rather than acute medical.

Medically monitored care (Level 3.7) is provided by an interdisciplinary staff under the direction of a licensed physician, with nursing care available at night and on weekends. It serves patients requiring intensive medical and psychological monitoring.

In plain terms: clinically managed care is a highly structured, therapeutically intensive residential program staffed by addiction specialists. Medically monitored care adds a layer of physician-directed medical oversight for patients with more complex clinical needs. This distinction affects the type of staff present, the nature of monitoring, and the interventions available. It also carries insurance and billing implications, as payers increasingly scrutinize whether the level billed matches the documented clinical evidence.

ASAM Level 3.1: Clinically Managed Low-Intensity Residential Services

Level 3.1 is the least intensive residential level. It is appropriate for patients whose recovery is aided by time in a stable, structured environment where they can practice coping skills, build self-efficacy, and make connections to community, including work, education, and family systems.

The typical patient has stable biomedical status, manageable emotional and behavioral symptoms, and a home environment that is insufficient to support sobriety without residential structure. Programming centers on 24-hour supportive oversight (not medical monitoring), skill-building, peer support, and community reintegration.

Level 3.1 is not a “less serious” level for patients who do not really need treatment. It is a clinically indicated level for patients whose dimensional profile calls for this type of structured support.

• Step-up triggers: emerging withdrawal symptoms requiring medical management, worsening psychiatric symptoms, or inability to maintain abstinence at this level.
• Step-down signals: demonstrated stability, skill acquisition, and readiness for outpatient care with community supports in place.

Within the Regal Recovery Alliance network, Level 3.1 offers the structured, dignified environment patients need to consolidate early gains before stepping down to outpatient care. Building healthy habits during this phase is a core component of programming at this level.

What Happened to Level 3.3? Understanding the 4th Edition Elimination

Many patients, families, and even clinicians will still encounter Level 3.3 in older materials, insurance documents, or other websites.

Level 3.3 was Clinically Managed Population-Specific High-Intensity Residential Services, designed for patients (often older adults or those with cognitive impairments) who needed a slower pace of treatment delivery. In the 4th Edition, it was eliminated because pace of treatment is now understood as a patient-centered consideration that should be individualized at any level, not a separate tier.

Practically, a patient who would once have been placed at Level 3.3 would now be placed at Level 3.1 or 3.5 with individualized pacing built into their treatment plan under the new Dimension 6.

Some older payer contracts and state regulations still reference Level 3.3. Patients should seek clarification from payers operating under updated criteria. During this transition period, the clinical intent of population-specific, individualized pacing is now embedded within 3.1 and 3.5 programming.

ASAM Level 3.5: Clinically Managed High-Intensity Residential Services

Level 3.5 is the highest clinically managed residential level, involving 20 or more hours of services per week with 24-hour oversight.

The typical patient has active SUD and/or co-occurring mental health diagnoses and requires round-the-clock structure to remain abstinent and safe. A key 4th Edition change: the former Level 3.2-WM is now incorporated here, meaning clinically managed residential withdrawal management is delivered within this level rather than as a separate tier.

The clinical structure includes intensive therapeutic programming (CBT, DBT, group and individual counseling), 24-hour staff oversight, a structured daily schedule, and integrated withdrawal management where applicable.

The 3.5 COE designation serves patients with more severe co-occurring mental health needs, providing enhanced psychiatric services within the residential setting. This is directly relevant to the 21.2 million adults with co-occurring disorders.

• Step-up triggers to 3.7: medical complications requiring physician oversight, psychiatric decompensation, or withdrawal severity exceeding clinically managed capacity.
• Step-down signals to 3.1 or outpatient: demonstrated stability and reduced psychiatric symptom severity.

In Regal’s network, the integration of withdrawal management within Level 3.5 means patients can begin stabilization and intensive treatment without disruptive transfers between facilities.

ASAM Level 3.7: Medically Monitored Intensive Inpatient Services

Level 3.7 is the most intensive residential level, requiring intensive medical and psychological monitoring in a 24-hour setting with nursing care available at night and on weekends, all under the direction of a licensed physician.

The defining feature versus Level 3.5 is physician-directed care and nursing availability. This level is for patients whose complexity requires medical oversight that nonphysician addiction specialists cannot safely provide: significant biomedical comorbidities, severe withdrawal risk, or complex psychiatric presentations that fall short of needing acute hospital-based Level 4 care.

Two new 4th Edition designations apply here. 3.7 BIO serves patients with particularly significant medical comorbidities requiring elevated biomedical monitoring. 3.7 COE serves patients with severe co-occurring conditions requiring physician-directed psychiatric and addiction treatment simultaneously.

• Step-up to Level 4: an acute medical or psychiatric emergency requiring hospital-based care.
• Step-down to Level 3.5: medical and psychiatric stability achieved and withdrawal management complete.

At Regal Recovery Alliance, Level 3.7 oversight is anchored by Medical Director Dr. Julio Meza, MD, whose credentials include the David Geffen School of Medicine at UCLA and a Fellowship in Addiction Medicine at UCLA. Combined with a 1:1.5 staff-to-patient ratio, this provides the physician-directed infrastructure medically complex patients require.

The Clinical Decision-Making Process: How Patients Move Between Levels

The actual logic of transitions is what most content omits, and it matters enormously.

Patients are continuously reassessed across all six ASAM dimensions. Transition and continued service criteria determine three directions:

• Step-up: worsening withdrawal, psychiatric decompensation, inability to maintain safety, or new biomedical findings requiring physician oversight.
• Step-down: stability achieved, skills acquired, reduced risk, and readiness for a less structured setting.
• Continued service: ongoing clinical need that has not yet resolved; the patient is progressing but has not met transition criteria.

The 4th Edition explicitly frames addiction as a chronic condition requiring ongoing management, which is why Level 1.0 Long-Term Remission Monitoring was introduced. Research indicates that implementing ASAM-based assessment is associated with improved 30-day retention for those beginning residential treatment, and retention is one of the strongest predictors of long-term recovery.

To restate the central myth-busting point: patients do not need to fail at a lower level before accessing a higher one. For some patients, 3.7 is the correct starting point from day one. Thorough documentation of dimensional criteria also supports insurance authorization and parity compliance, a point underscored by the 2025 UnitedHealthcare $450,000 parity fine for failing to use the full ASAM criteria.

Why Transitions Are the Most Dangerous Moment in Addiction Treatment

The period of transition between levels, especially when it involves changing providers, is one of the highest-risk moments in recovery.

When patients must change facilities, clinical teams, and therapeutic relationships to move between levels, continuity is disrupted, trust is broken, and the risk of dropout or relapse climbs. Given that only about 9.1% of Americans who need treatment receive it at a specialized facility, every dropout during a transition represents a potentially catastrophic outcome.

The specific vulnerabilities are well documented: loss of therapeutic alliance, gaps in medication management (especially MAT), disruption of peer support, administrative authorization delays, and the psychological stress of change during an already fragile period.

A unified multi-level network changes the equation. When all levels (3.1 through 3.7) exist within a single network under a single clinical standard, transitions become internal handoffs rather than external referrals. There is also a health equity dimension: research shows Black/African American patients are significantly more likely to decline recommended ASAM levels, and fragmentation disproportionately affects underserved populations. A unified, culturally responsive network helps close that gap.

How Regal Recovery Alliance Eliminates the Gaps: A Unified 3.1–3.7 Network

Regal Recovery Alliance was built around the residential spectrum. Its network spans ASAM residential levels across five San Fernando Valley facilities: Regal Treatment in Winnetka, Aura Detox in Santa Clarita, First Haven Recovery in Sherman Oaks, Road to Recovery in Sun Valley, and Elevations in Northridge. Covering the full residential continuum within one network is a significant clinical differentiator; most providers offer only one or two levels.

All facilities operate under a single standard of clinical excellence, applying identical rigorous protocols. Clinical leadership comes from Dr. Julio Meza, MD, providing the physician-directed oversight required for Level 3.7. The 1:1.5 staff-to-patient ratio significantly exceeds industry standards, supported by 24/7 medical supervision.

Regal’s dual diagnosis approach treats SUD and co-occurring conditions (depression, anxiety, PTSD, and bipolar disorder) simultaneously, directly aligned with the 4th Edition’s COE designations and the reality that 34.5% of adults with any mental illness also meet criteria for SUD. Therapeutic offerings include CBT, DBT, EMDR, trauma therapy, motivational interviewing, MAT, family therapy, group counseling, and holistic wellness programming.

The practical benefit is clear: if clinical needs change, whether stepping up from 3.1 to 3.7 or stepping down as stability returns, the transition is managed internally, preserving relationships and continuity. Admissions are available 24/7 with confidential insurance verification.

Co-Occurring Enhanced (COE) Levels: What Dual Diagnosis Patients Need to Know

Dual diagnosis is the norm, not the exception. Approximately 21.2 million adults have co-occurring SUD and mental illness, and 34.5% of adults with any mental illness also meet criteria for SUD.

The COE designations exist for patients whose mental health needs are severe enough to require enhanced psychiatric services within the residential setting. A 3.5 COE program provides all the services of Level 3.5 plus enhanced behavioral health capabilities. A 3.7 COE adds physician-directed psychiatric management to the intensive inpatient framework.

This affects placement directly. A patient with severe PTSD and opioid use disorder may need 3.5 COE rather than standard 3.5. A patient with bipolar disorder and alcohol dependence experiencing decompensation may need 3.7 COE.

Traditional models treated mental illness and addiction sequentially. The COE framework, like Regal’s integrated approach, treats both simultaneously, which the evidence supports as more effective. Understanding the connection between mental health and addiction recovery is essential for anyone with a known or suspected co-occurring condition, and asking whether a provider is equipped for COE-level care is an essential question.

Insurance Coverage, Parity, and What to Expect When Paying for Residential Care

The Mental Health Parity and Addiction Equity Act requires that coverage for SUD treatment be no more restrictive than coverage for medical and surgical conditions, and that ASAM criteria be used to determine medical necessity. Enforcement is real and growing: in September 2025, Delaware fined UnitedHealthcare $450,000 for failing to use the full set of ASAM criteria.

A critical gap remains for older adults: Medicare does not cover ASAM Level 3 (residential) care. Of the five million Medicare beneficiaries with SUD, only 1 in 4 underwent treatment. Patients relying on Medicare should explore alternative coverage options.

“Medical necessity” in practice means authorization is tied to documented dimensional criteria. The more thoroughly a clinician documents the rationale, the stronger the authorization case.

Regal Recovery Alliance accepts most major PPO plans, including Anthem Blue Cross, Aetna, United Healthcare, Cigna, Kaiser Permanente, Highmark, Horizon Blue Cross, NYSHIP, GEHA, and UMR, with cash pay options and 24/7 confidential verification. When evaluating providers, families can also look for the ASAM Level of Care Certification (in partnership with CARF International), which independently verifies a program’s capacity to deliver ASAM-aligned care at Levels 3.1, 3.5, and 3.7.

How to Know Which Level Is Right: A Practical Guide for Patients and Families

Level determination is always a clinical assessment, never self-selection. Still, understanding the framework helps families advocate and ask the right questions.

• Level 3.1 signals: medically stable, manageable psychiatric symptoms, needs structure and community connection, has foundational coping skills, but home environment poses relapse risk.
• Level 3.5 signals: needs intensive daily programming (20+ hours weekly), may need withdrawal management, co-occurring symptoms requiring intensive but non-physician-directed management, cannot stay safe in a less structured setting.
• Level 3.7 signals: requires physician-directed monitoring, significant biomedical comorbidities, complex psychiatric presentation, or severe withdrawal risk.

A good provider conducts a thorough dimensional assessment across all six ASAM dimensions before recommending a level. A provider that offers only one level cannot safely manage a step-up or step-down without disrupting care, which is precisely why multi-level network coverage matters. Regal’s 24/7 admissions and confidential insurance verification make the initial assessment accessible and low-barrier.

The Evidence Behind ASAM-Guided Treatment: Why Proper Placement Matters

ASAM-based placement is clinically meaningful, not merely a regulatory box to check. Three decades of outcomes research show that patients optimally matched to the appropriate level have lower hospital utilization, lower attrition, and reduced substance use at follow-up. Implementation of ASAM-based assessment is specifically associated with improved 30-day retention for those beginning residential treatment.

The need keeps growing. The prevalence of individuals requiring SUD treatment rose from 8.2% in 2013 to 17.1% in 2023, more than doubling in a decade, while treatment receipt has not kept pace. Proper placement is one of the few levers available to improve outcomes among those who do reach care.

Health equity remains a challenge. Research found that 42% of patients declined all ASAM levels of care at assessment, with Black/African American patients significantly more likely to decline. This underscores the need for culturally responsive assessment that addresses social determinants of health, now explicitly built into Dimension 6. As more states adopt the 4th Edition, ASAM-aligned care is becoming a licensing and reimbursement requirement, making fluency in this framework essential for providers and informed patients alike. Why evidence-based therapies make a difference in achieving these outcomes is a question every patient and family deserves a clear answer to.

Conclusion: Matching the Right Level to the Right Moment in Recovery

The ASAM residential continuum (Levels 3.1 through 3.7) is not a hierarchy of severity. It is a clinical toolkit. Each level serves a specific patient profile at a specific moment in recovery, and the ability to move fluidly between levels within a unified network is what separates fragmented care from genuine recovery.

The 4th Edition reflects a more sophisticated, individualized, and continuous approach: the elimination of Level 3.3, the integration of withdrawal management into 3.5, the introduction of COE designations, and the embrace of the chronic care model. With 48.4 million Americans experiencing a past-year SUD and fewer than 10% receiving specialized treatment, the decisions made at placement and at every transition carry profound consequences.

An informed patient or family is empowered to ask better questions and choose providers equipped to support the full arc of recovery. As parity enforcement strengthens and state adoption accelerates, the providers best positioned to serve patients are those who have built their infrastructure around the full residential continuum.

Take the First Step: Speak With Regal Recovery Alliance Today

Understanding the clinical framework matters, but the most important step is reaching out for help.

Regal Recovery Alliance is a unified network of five accredited facilities across Los Angeles County, covering ASAM residential Levels 3.1 through 3.7 under a single standard of clinical excellence, with 24/7 medical supervision and a 1:1.5 staff-to-patient ratio. The network accepts most major PPO plans, offers cash pay options, and provides confidential insurance verification. The first call is free and confidential.

Call or text (424) 235-8288 any time, day or night, to speak with an admissions specialist who can conduct a confidential assessment and explain which level of care may be appropriate.

For more information, visit regalrecoveryalliance.com or email [email protected].

Recovery is possible. The right level of care, matched to the right moment, makes all the difference.